The global heparin market size is expected to reach USD 7.55 Billion in 2028 at a CAGR of 1.4% during the forecast period, according to the latest report by Reports and Data.
The global heparin market size is expected to reach USD 7.55 Billion in 2028 at a CAGR of 1.4% during the forecast period, according to the latest report by Reports and Data. Rising demand for heparin due to high prevalence of chronic conditions such as last-stage renal disease, atrial fibrillation, and cardiovascular diseases, increasing number of surgical procedures performed across the globe, and extensive R&D activities to explore other clinical and therapeutic roles of heparin are key factors expected to drive market revenue growth over the forecast period. In addition, heparin is used for various off-label indications in hospitals and for treatment and prevention of venous thromboembolism events in post-surgical patients, and this is another factor expected to contribute to revenue growth of the market going ahead.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/4154
Heparin is a widely used anticoagulant that significantly reduces clotting risks and thromboembolism events after major surgical interventions. Heparin is a naturally occurring polysaccharide belonging to the family of glycosaminoglycans that are primarily present in mast cell. Heparin exerts anticoagulant properties by binding to antithrombin and enhancing the subsequent inhibitory effect of antithrombin on thrombin and activated factor X. The currently available heparin is mostly obtained from animal tissue. However, due to growing concerns regarding animal safety, several approaches for bioengineering heparin such as microbial production and chemoenzymatic modification among others are increasingly being researched on. Major players are also focusing on R&D for its potential clinical and therapeutic applications such as anti-inflammatory and anti-tumor activities as well as role in prevention of infectious diseases, besides its use as an anticoagulant. Heparin has antineoplastic properties along with anticoagulant properties, and this is expected to result in increasing research activities to explore potential of heparin for treating various other conditions. This, in turn, is expected to significantly contribute to market revenue growth going ahead.
Venous thromboembolism prophylaxis with anticoagulant therapy is often used for cancer patients who are hospitalized or undergoing chemotherapy. However, possible risks of bleeding with the use of heparin and its derivatives have limited its use in management of cancer patients in other therapeutic settings, and this could hamper market growth to a certain extent over the forecast period.
Some Key Highlights from the Report:
-
- Low-molecular-weight heparin (LMWH) segment is expected to account for largest revenue share over the forecast period, attributable to increasing preference for LMWH over unfractionated heparin in clinical settings, in treatment of venous thromboembolism events, and in obstetrics due to low risk of bleeding and other complications associated with it.
- Subcutaneous route of administration is expected to register significant revenue growth during the forecast period, owing to growing preference for subcutaneous therapy of heparin, lesser incidence of pain and higher patient comfort, and low risk of recurrent thromboembolism when treated with subcutaneous injection of low-molecular weight heparin.
- Venous thromboembolism is expected to dominate other application segments between 2021 and 2028 owing to increasing incidence of VTE among post-operative patients and rising need for anticoagulant therapy with low-molecular weight heparin.
- Hospital pharmacies segment is expected to register steady revenue CAGR over the forecast period, attributable to increasing hospital admission of patients needing surgeries or dialysis, availability of high-quality heparin derivatives, growing number of outpatient procedures, and increasing reliance on pharmacists and doctors.
- North America is expected to account for a significantly large revenue share over the forecast period, attributable to rising incidence of cardiovascular diseases and chronic illnesses, rising number of surgical procedures performed, availability of high-end medical facilities and medications, and robust presence of key players in the market.
Competitive Landscape:
The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, merger and acquisitions, collaborations, and joint ventures to gain robust footing in the market.
Top Companies Profiled in the Report:
Pfizer Inc., Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Sanofi SA, B. Braun Melsungen AG, GlaxoSmithKline PLC, LEO Pharma A/S, Aspen Holdings, Fresenius SE & Co. KGaA, and Viatris Inc.
To know more about the report, visit @ https://www.reportsanddata.com/report-detail/heparin-market
Heparin Market Segmentation:
Product Type Outlook (Revenue, USD Billion; 2018-2028)
- Unfractionated Heparin
- Low Molecular Weight Heparin
- Ultra-low Molecular Weight Heparin
Route of Administration (Revenue, USD Billion; 2018-2028)
- Subcutaneous
- Intravenous
Regional Outlook:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Latin America (Brazil, Rest of LATAM)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/4154
This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.
Explore Latest Trending Research Reports By Reports and Data’s:
Veterinary Electrosurgery Market Analysis, By Products (Bipolar Electrosurgery Instruments, Monopolar Electrosurgery Instruments), By Applications (General Surgery, Dental Surgery), By End use (Veterinary Hospitals, Veterinary Clinics) Forecasts To 2027
Contrast Media Market , By Type (Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media, Barium-based Contrast Media), By Modality (X-ray/CT, MRI, Ultrasound), By Route of Administration (Intravascular Route, Oral Route, Rectal Route, Others) By Application, By End Use, and Region Forecast to 2028
Artificial Intelligence in Drug Discovery Market Analysis, By Drug Type (Small Molecule, Large Molecule), By Offerings (Software, Services), By Technology (Deep Learning, Machine Learning), By Applications, By End Use And By Region Forecasts To 2027
Bone Densitometer Market Size, Growth & Analysis, By Technology (Axial Bone Densitometry, Peripheral Bone Densitometry), By Application (Osteoporosis And Osteopenia, Cystic Fibrosis Rheumatoid Arthritis), By End Use And By Region Forecasts To 2027
Diagnostic Imaging Services Market Share, Growth & Analysis, By Type (X-ray Imaging, MRI, CT, Ultrasound), By Technology (2D, 3D/4D) By Application (Orthopedics, Cardiovascular, Neurology, Others) And By Region Forecasts To 2027
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs